Results 221 to 230 of about 1,116,011 (264)

Author Correction: Optical coherence tomography in coronary atherosclerosis assessment and intervention. [PDF]

Nat Rev Cardiol
Araki M, Park SJ, Dauerman HL, Uemura S, Kim JS, Di Mario C, Johnson TW, Guagliumi G, Kastrati A, Joner M, Holm NR, Alfonso F, Wijns W, Adriaenssens T, Nef H, Rioufol G, Amabile N, Souteyrand G, Meneveau N, Gerbaud E, Opolski MP, Gonzalo N, Tearney GJ, Bouma B, Aguirre AD, Mintz GS, Stone GW, Bourantas CV, Räber L, Gili S, Mizuno K, Kimura S, Shinke T, Hong MK, Jang Y, Cho JM, Yan BP, Porto I, Niccoli G, Montone RA, Thondapu V, Papafaklis MI, Michalis LK, Reynolds H, Saw J, Libby P, Weisz G, Iannaccone M, Gori T, Toutouzas K, Yonetsu T, Minami Y, Takano M, Raffel OC, Kurihara O, Soeda T, Sugiyama T, Kim HO, Lee T, Higuma T, Nakajima A, Yamamoto E, Bryniarski KL, Di Vito L, Vergallo R, Fracassi F, Russo M, Seegers LM, McNulty I, Park S, Feldman M, Escaned J, Prati F, Arbustini E, Pinto FJ, Waksman R, Garcia-Garcia HM, Maehara A, Ali Z, Finn AV, Virmani R, Kini AS, Daemen J, Kume T, Hibi K, Tanaka A, Akasaka T, Kubo T, Yasuda S, Croce K, Granada JF, Lerman A, Prasad A, Regar E, Saito Y, Sankardas MA, Subban V, Weissman NJ, Chen Y, Yu B, Nicholls SJ, Barlis P, West NEJ, Arbab-Zadeh A, Ye JC, Dijkstra J, Lee H, Narula J, Crea F, Nakamura S, Kakuta T, Fujimoto J, Fuster V, Jang IK.   +113 more
europepmc   +1 more source

Artificial intelligence-powered insights into high-risk, non-obstructive coronary atherosclerosis: a case report. [PDF]

Eur Heart J Case Rep
Provera A, Andreini D, Petersen K, Gallinoro E, Conte E.   +4 more
europepmc   +1 more source

Absence of platelet overactivation and thrombosis formation among patients with coronary atherosclerosis disease after vaccination against SARS-CoV-2. [PDF]

Heliyon
Xu H, Zhao X, Zhang P, Zhang Y, Zhou Q, Wu H, Fan B, Zhang S, Wu H.   +8 more
europepmc   +1 more source

Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis. [PDF]

Circ Res
Manzo OL, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S, Smimmo M, Hu Y, Bucci MR, Borczuk A, Elemento O, Freed JK, Norata GD, Di Lorenzo A.   +13 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The Role of Adipocytokines in Coronary Atherosclerosis

Current Atherosclerosis Reports, 2017
The aim of this review is to overview the pathophysiological role of adipocytokines in atherogenesis, focusing on their potential role as biomarkers of coronary disease.Several lines of evidence indicated adipose tissue not only as depot but rather as an endocrine organ. In this context, the balance between pro- and anti-inflammatory adipocytokines has
L. Liberale, A. Bonaventura, A. Vecchié, Casula Matteo, F. Dallegri, F. Montecucco, F. Carbone   +6 more
semanticscholar   +5 more sources

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Journal of the American Medical Association (JAMA), 1998
CONTEXT Although cholesterol-reducing treatment has been shown to reduce fatal and nonfatal coronary disease in patients with coronary heart disease (CHD), it is unknown whether benefit from the reduction of low-density lipoprotein cholesterol (LDL-C) in
J. Downs, M. Clearfield, S. Weis, E. Whitney, D. Shapiro, P. Beere, A. Langendorfer, E. Stein, W. Kruyer, A. Gotto   +9 more
semanticscholar   +1 more source

The neglected coronary atherosclerosis

Atherosclerosis, 1983
A study of the natural history of coronary heart disease by means of gross inspection and light microscopy, carried out on 640 subjects aged 1-50 years who had died of violent accidents, revealed a grossly neglected coronary atherosclerosis. It included fibromuscular plaques, intimal necrotic areas and incorporated microthrombi present in the ...
C. Velican, Doina Velican
openaire   +3 more sources

Pharmacotherapy of coronary atherosclerosis

Expert Opinion on Pharmacotherapy, 2009
Despite advances in the pharmacotherapy of atherosclerosis, the most successful agents used to treat this disease - statins - remain ineffective for the primary or secondary prevention of myocardial infarction in about two-thirds of patients. The lack of a more robust treatment effect underscores the limitations of lipid lowering alone and emphasizes ...
Renu Virmani, Marc Vorpahl, Aloke V. Finn, Miranda C.A. Kramer, Frank D. Kolodgie   +4 more
openaire   +3 more sources